CEPAR researchers and collaborators have developed a simulation model that offers an important tool for the economic evaluation of treatments and interventions for type 1 diabetes.
You are here
News
CEPAR researchers Associate Professor Jeromey Temple and Dr Tom Wilson, in collaboration with Professors Sandra Eades and Margaret Kelaher at the University of Melbourne and Dr Andrew Taylor at the Charles Darwin University, outline in this paper a new multi-state cohort-component projection model to project the Australian population by Indigenous status.
New research released by CEPAR researchers Dr Tim Neal and Professor Mike Keane on COVID-19 consumer panic shopping has shown that Australian consumers top the globe in panic buying habits – in speed and scale.
Professor Warwick McKibbin AO, CEPAR Chief Investigator and Director of Policy Engagement, has been appointed to the Australian Treasury Expert Panel on COVID-19.
Noted experts, including CEPAR Professors Peter McDonald and John Piggott, A/Professor Jeromey Temple and Dr Tom Wilson report on the latest research into population ageing in Australia in a special issue of Australian Population Studies.
A team led by Scientia Professor Kaarin Anstey, with Professor Michael Regan, Dr Kim Kiely, Professor Mari Velonaki, Stephen Cratchley, Dr Lesley Ross, and Professor John McCallum, have been awarded funding in the latest rounds of ARC Linkage Projects outcomes.
The CEPAR fact sheet on COVID-19 and the demographic distribution of health and economic risks provides a current snapshot of the risks of workplace infection exposure, morbidity, and job losses across the Australian population, particularly for people aged 55 years and over.
Researchers from ANU and UNSW Sydney have shown how the Federal Government's JobKeeper scheme could be phased down as the economy re-opens and recovery takes shape.
CEPAR researchers Professor Robert Cumming and Dr Saman Khalatbari-Soltani highlight in their recent paper the importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards.